Semaglutide is a synthetic peptide that belongs to a class of medications known as GLP-1 receptor agonists. Marketed under brand names such as Ozempic, Rybelsus, and Wegovy, semaglutide has gained widespread recognition for its role in managing type 2 diabetes and, more recently, for its efficacy in weight loss. As a GLP-1 receptor agonist, it mimics the action of the natural hormone GLP-1, which is involved in regulating blood sugar levels, insulin secretion, and appetite.
